AzTrials
AzTrials

AnxietyPOST-RCTNCT04070183

POST Facilitation for Community Dwelling Older Adults (POST-RCT)

A study testing POST Facilitation and Home Safety Evaluation in people with Anxiety and Depression, run by Indiana University at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We propose to study the effects of Physician Orders for Scope of Treatment (POST) Facilitation in a randomized controlled trial in a population of community dwelling older adults who qualify for POLST facilitation, including those with normal cognition and those with Alzheimer's Disease and Related Disorders. Read more about this study

Who is it for?
Ages 65 years and older
What is being tested?
POST Facilitation and Home Safety Evaluation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
389 participants
Where
3 sitesUnited States
Study dates
11 May 2020to 29 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patients:
  • 65 or older
  • have decision making capacity OR a qualified surrogate decision maker
  • must meet one of the following index scores:
  • Gagne Mortality Index score of 7 or greater (30% mortality risk)
  • Medicare Criteria for Hospice Admission: Functional Assessment Staging Tool (FAST) Index (Advanced Alzheimer's disease and related dementia) 7c or higher plus one or more comorbid conditions.
Show all 16Show fewer
  • Seattle Heart Failure Model (congestive heart failure): score conferring a one-year mortality risk of 30% or greater
  • Eastern Cooperative Oncology Group (ECOG) performance status (metastatic cancer): Patients with an impaired performance score (greater than zero)
  • Liu Comorbidity Index (End Stage Renal Disease): Patients with a score of 10 or greater
  • blood results (B), age (A), respiratory variables (airflow obstruction, exacerbations, smoking) (R) and comorbidities (C) (BARC) Index for chronic obstructive pulmonary disease (COPD): high risk group
  • Model for End Stage Liver Disease (MELD) Index
  • must be able to pass consent verification
  • must not be enrolled in hospice
  • must not have an acute illness
  • must give patient's provider opportunity to review the "surprise question" (e.g. would you be surprised if the patient died in the next year) to confirm anticipated mortality within the next year (14 days to respond)
  • must not have a POST form on file.

Who cannot join

  • lack of a patient or surrogate decision maker who can participate in POLST facilitation (for non-decisional patients a health care representative (HCR) or designated power of attorney for health care (DPOA-HC) must enroll with them)
  • patients who are already enrolled in hospice
  • patients or surrogates who cannot pass consent verification
  • patients or surrogates who do not speak English
  • patients with a POST form on file
  • patients who are not community-dwelling

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Eskenazi Health

    Indianapolis, Indiana, 46202

  • IU Health Methodist Hospital

    Indianapolis, Indiana, 46202

  • IU Health University Hospital

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

Official title: POST Facilitation for Community Dwelling Older Adults With and Without Dementia

We propose to study the effects of Physician Orders for Scope of Treatment (POST) Facilitation in a randomized controlled trial in a population of community dwelling older adults who qualify for POLST facilitation, including those with normal cognition and those with Alzheimer's Disease and Related Disorders.

Read the detailed description

The POLST paradigm, which stands for Physician Orders for Life Sustaining Treatment, was developed to address inconsistencies between care received and patient and family wishes for treatment, with an aim to increase concordant care. The POLST paradigm is nationally recognized and implemented in a number of states under different names. In Indiana, for example, it is called "Physician Orders for Scope of Treatment" (POST). Because of this, all patient facing materials will refer to POST, however, we use the terms POST and POLST interchangeably in this proposal.

POLST affects delivery of medical interventions and improved concordance between patient preferences and care received.

Our specific aims are:

  1. To test the effect of high quality POLST Facilitation delivered in the home compared to attention control on: a.discordance between preferences for treatment and treatments received in the subsequent 12 months (primary outcome).
  2. To test the effect of POLST Facilitation on intermediate outcomes including:
  3. The proportion of patients with a completed POLST form in the electronic medical record within 3 months of POLST Facilitation
  4. Decision quality regarding ACP as measured by the Decisional Conflict Scale, the advance care planning (ACP) Engagement Survey,and the POLST knowledge survey
  5. To test the effect of a POLST Facilitation on secondary outcomes of cost and end-of-life care including:
  6. Receipt of life-sustaining interventions or hospice within the 30 days prior to death, for patients who die during the year after POLST Facilitation
  7. The psychological well-being (anxiety, depression,and post traumatic stress) of surrogate decision makers after the patient's death
  8. The cost effectiveness of POLST Facilitation for the prevention of ICU admissions and hospitalizations
Being tested
POST Facilitation, Home Safety Evaluation
Keywords
surrogate decision making, medical decision making, advance care planning, family communication
Medical subject headings
Anxiety Disorders, Depression, Stress Disorders, Post-Traumatic, Personal Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • POST FacilitationBehavioural

    Also called Respecting Choices Advanced Steps

    Advanced steps is initiated as a component of quality end-of-life care for frail elders and those whose death in the next 12 months would not be unexpected. The AS planning conversation is focused on goals of care to make timely, proactive, and specific end-of-life decisions. Ideally, these decisions are converted into medical orders that can be followed throughout the continuum of care. The Physician Orders for Life-Sustaining Treatment (POLST) program is the nationally recognized model for this stage of planning.

  • Home Safety EvaluationBehavioural

    Nurse evaluation and education on how to improve safety at home for community dwelling older adults (examples of education and evaluation includes fall risks, fire and carbon monoxide (CO) detectors, transferring safety (e.g. in and out of the tub, bed, etc.) and others.

Study groups in NCT04070183
Study groupRoleWhat they receive
Attention Control (Home Safety Evaluation)OtherA nurse will complete a home visit with the patient and their surrogate decision maker or other family member (if they've designated one), in which he or she will provide suggestions on how to improve the safety of the patient's home.
Receives: Behavioral: Home Safety Evaluation
Intervention (POST Facilitation)ExperimentalA nurse will complete a home visit with the patient and their surrogate decision maker or other family (if they've designated one), in which he or she will provide education about the POST form. The POST facilitators will be nurses trained using the Respecting Choices Advanced Steps model.
Receives: Behavioral: POST Facilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Discordance between treatment preferences and treatment received 12 months after POST Facilitation

    Chart review and comparative statistics will be used to determine discordance between patient/family preferences and care received at the end of life.

    Measured: Assessed 12 months from the date that the patient receives POST facilitation or home safety evaluation

Secondary outcomes (8)
  1. Proportion of patients who have a completed POST form 3 months after receiving POST Facilitation

    Chart review and comparative statistics will be used to determine any correlations between intervention and completion of a POST form

    Measured: Assessed 3 months from the date that the participant receives POST facilitation or a home safety evaluation

  2. Decision conflict

    Decisional Conflict Scale (DCS)

    The DCS is used to assess decision conflict

    Scores range from 0 (no decisional conflict) to 100 (high decisional conflict) 0= 'strongly agree'; 1= 'agree'; 2= 'neither agree nor disagree'; 3= 'disagree'; 4= 'strongly disagree'.

    TOTAL SCORE 16 items are: a) summed; b) divided by 16; and c) multiplied by 25 Other papers may present scores ranging from 1 [low decisional conflict] to 5 [high decisional conflict].

    Measured: Assessed 3 months from the date that the participant receives POST facilitation or a home safety evaluation

  3. Decision quality- ACP engagement

    Advance Care Planning (ACP) engagement survey

    Measured: Assessed 3 months from the date that the participant receives POST facilitation or a home safety evaluation

  4. Decision quality- POLST Knowledge

    POLST Knowledge Survey

    Measured: Assessed 3 months from the date that the participant receives POST facilitation or a home safety evaluation

  5. Effect of the intervention on cost and end of life care (EOL) for patients who die within 12 months of the intervention

    Will use comparative statistics to determine any correlations between intervention and EOL care (life sustaining treatments received and hospice enrollment within 30 days of death)

    Measured: Assessed by chart review 12 months from the date that the participant receives POST facilitation or a home safety evaluation

  6. Effect of the intervention on psychological well-being (anxiety)

    Generalized Anxiety Disorder- 7 (GAD-7) (7 item inventory of anxiety)- assesses subject's self-reported anxiety for the last two weeks.

    Scores range from 0-21 0= 'Not at all'; 1= 'Several Days'; 2= 'More than half the days'; 3= 'Nearly every day' Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.

    When used as a screening tool, further evaluation is recommended when the score is 10 or greater.

    Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for GAD.

    Measured: Assessed 3 months from the date that the participant receives POST facilitation or a home safety evaluation

  7. Effect of the intervention on psychological well-being (depression)

    Patient Health Questionnaire-8 (PHQ-8: item inventory of depression)

    Scores range from 0-24 *note that this scale is adapted from the PHQ-9, to remove the question about suicidal ideation.

    0= 'Not at all'; 1= 'Several Days'; 2= 'More than half the days'; 3= 'Nearly every day' Higher scores indicate higher severity of depressive symptoms.

    Measured: Assessed 3 months from the date that the participant receives POST facilitation or a home safety evaluation

  8. Effect of the intervention on psychological well-being (post traumatic stress)

    (IES-R (Impact of Events Scale- Revised- inventory for PTSD) Scores range from 0-88 0= 'Not at all'; 1= 'A little bit'; 2= 'Moderately'; 3= 'Quite a bit'; 4= 'Extremely' The Impact of Event Scale-Revised (Weiss \& Marmar, 1997) is a 22-item scale which is rated on a 0 (not at all) to 4 (extremely) scale with respect to how distressing each item has been during the past week. Scale scores are formed for the three subscales, which reflect intrusion (8 items), avoidance (8 items), and hyperarousal (6 items).

    Measured: Assessed 3 months from the date that the participant receives POST facilitation or a home safety evaluation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2019
  2. Study start11 May 2020
  3. Primary completion29 Jul 2025
  4. Study completion29 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Arm 1- Attention Control group Arm 2- Intervention group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
389 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04070183
Sponsor's protocol ID
1905850231
Other IDs
R01AG056618
Acronym
POST-RCT
Status last verified
Nov 2025
First submitted
24 Aug 2019
Last updated
26 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will construct a de-identified data set that could be available to other researchers. Survey data, technical appendix and statistical code will be preserved and shared via the NIH-supported National Archive of Computerized Data on Aging's (NACDA) Open Aging Repository (OAR).

Publications

  • Torke AM, Hickman S, Wocial L, Monahan PO, Burke ES, Slaven J, Ziemba K, Montgomery C, Koch S, Cavanaugh M, Fox Ludden E. Planning Ahead: protocol for a randomised trial of advance care planning for community dwelling older adults at increased mortality risk. BMJ Open. 2025 May 24;15(5):e102186. doi: 10.1136/bmjopen-2025-102186.

    PubMed 40413042

Questions about this trial

What is this clinical trial studying?

A study testing POST Facilitation and Home Safety Evaluation in people with Anxiety and Depression, run by Indiana University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Discordance between treatment preferences and treatment received 12 months after POST Facilitation (time frame: Assessed 12 months from the date that the patient receives POST facilitation or home safety evaluation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04070183, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in